Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.
2.

Pin1 is related with clinical stage of papillary thyroid carcinoma.

Jiang L, Chu H, Zheng H.

World J Surg Oncol. 2016 Mar 31;14(1):95. doi: 10.1186/s12957-016-0847-z.

3.

Mycobacterium tuberculosis Peptidyl-Prolyl Isomerases Also Exhibit Chaperone like Activity In-Vitro and In-Vivo.

Pandey S, Sharma A, Tripathi D, Kumar A, Khubaib M, Bhuwan M, Chaudhuri TK, Hasnain SE, Ehtesham NZ.

PLoS One. 2016 Mar 16;11(3):e0150288. doi: 10.1371/journal.pone.0150288. eCollection 2016.

4.

Peptidyl Prolyl Isomerase PIN1 Directly Binds to and Stabilizes Hypoxia-Inducible Factor-1α.

Han HJ, Kwon N, Choi MA, Jung KO, Piao JY, Ngo HK, Kim SJ, Kim DH, Chung JK, Cha YN, Youn H, Choi BY, Min SH, Surh YJ.

PLoS One. 2016 Jan 19;11(1):e0147038. doi: 10.1371/journal.pone.0147038. eCollection 2016. Erratum in: PLoS One. 2016;11(3):e0151517.

5.

Pin1-mediated Modification Prolongs the Nuclear Retention of β-Catenin in Wnt3a-induced Osteoblast Differentiation.

Shin HR, Islam R, Yoon WJ, Lee T, Cho YD, Bae HS, Kim BS, Woo KM, Baek JH, Ryoo HM.

J Biol Chem. 2016 Mar 11;291(11):5555-65. doi: 10.1074/jbc.M115.698563. Epub 2016 Jan 6.

PMID:
26740630
6.

Knockdown of Pin1 leads to reduced angiogenic potential and tumorigenicity in glioblastoma cells.

Atabay KD, Yildiz MT, Avsar T, Karabay A, Kiliç T.

Oncol Lett. 2015 Oct;10(4):2385-2389. Epub 2015 Jul 20.

7.

Negative Regulation of Peptidyl-Prolyl Isomerase Activity by Interdomain Contact in Human Pin1.

Wang X, Mahoney BJ, Zhang M, Zintsmaster JS, Peng JW.

Structure. 2015 Dec 1;23(12):2224-33. doi: 10.1016/j.str.2015.08.019. Epub 2015 Oct 22.

PMID:
26602185
8.

Investigating Dynamic Interdomain Allostery in Pin1.

Peng JW.

Biophys Rev. 2015 Jun 1;7(2):239-249. Epub 2015 Apr 22.

PMID:
26495045
9.

Pin1 facilitates NF-κB activation and promotes tumour progression in human hepatocellular carcinoma.

Shinoda K, Kuboki S, Shimizu H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Miyazaki M.

Br J Cancer. 2015 Nov 3;113(9):1323-31. doi: 10.1038/bjc.2015.272. Epub 2015 Oct 13.

PMID:
26461058
10.

Stereochemical Control in the Still-Wittig Rearrangement Synthesis of Cyclohexyl (Z)-Alkene Inhibitors of Pin1.

Chen XR, Fan SA, Ware RI, Etzkorn FA.

PLoS One. 2015 Oct 7;10(10):e0139543. doi: 10.1371/journal.pone.0139543. eCollection 2015.

11.

ATR Plays a Direct Antiapoptotic Role at Mitochondria, which Is Regulated by Prolyl Isomerase Pin1.

Hilton BA, Li Z, Musich PR, Wang H, Cartwright BM, Serrano M, Zhou XZ, Lu KP, Zou Y.

Mol Cell. 2015 Oct 1;60(1):35-46. doi: 10.1016/j.molcel.2015.08.008. Epub 2015 Sep 18.

PMID:
26387736
12.

Prolyl isomerase Pin1 negatively regulates AMP-activated protein kinase (AMPK) by associating with the CBS domain in the γ subunit.

Nakatsu Y, Iwashita M, Sakoda H, Ono H, Nagata K, Matsunaga Y, Fukushima T, Fujishiro M, Kushiyama A, Kamata H, Takahashi S, Katagiri H, Honda H, Kiyonari H, Uchida T, Asano T.

J Biol Chem. 2015 Oct 2;290(40):24255-66. doi: 10.1074/jbc.M115.658559. Epub 2015 Aug 14.

PMID:
26276391
13.

A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1.

Jiang B, Pei D.

J Med Chem. 2015 Aug 13;58(15):6306-12. doi: 10.1021/acs.jmedchem.5b00411. Epub 2015 Jul 28.

PMID:
26196061
14.

Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy.

Kondo A, Shahpasand K, Mannix R, Qiu J, Moncaster J, Chen CH, Yao Y, Lin YM, Driver JA, Sun Y, Wei S, Luo ML, Albayram O, Huang P, Rotenberg A, Ryo A, Goldstein LE, Pascual-Leone A, McKee AC, Meehan W, Zhou XZ, Lu KP.

Nature. 2015 Jul 23;523(7561):431-6. doi: 10.1038/nature14658. Epub 2015 Jul 15.

15.

Roles of Prolyl Isomerases in RNA-Mediated Gene Expression.

Thapar R.

Biomolecules. 2015 May 18;5(2):974-99. doi: 10.3390/biom5020974. Review.

16.

Regulation of AU-Rich Element RNA Binding Proteins by Phosphorylation and the Prolyl Isomerase Pin1.

Shen ZJ, Malter JS.

Biomolecules. 2015 Apr 14;5(2):412-34. doi: 10.3390/biom5020412. Review.

17.

Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.

Rajbhandari P, Ozers MS, Solodin NM, Warren CL, Alarid ET.

J Biol Chem. 2015 May 29;290(22):13749-62. doi: 10.1074/jbc.M114.621698. Epub 2015 Apr 12.

PMID:
25866209
18.

The Rab2A GTPase promotes breast cancer stem cells and tumorigenesis via Erk signaling activation.

Luo ML, Gong C, Chen CH, Hu H, Huang P, Zheng M, Yao Y, Wei S, Wulf G, Lieberman J, Zhou XZ, Song E, Lu KP.

Cell Rep. 2015 Apr 7;11(1):111-24. doi: 10.1016/j.celrep.2015.03.002. Epub 2015 Mar 26.

19.

The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease.

Blair LJ, Baker JD, Sabbagh JJ, Dickey CA.

J Neurochem. 2015 Apr;133(1):1-13. doi: 10.1111/jnc.13033. Epub 2015 Feb 24. Review.

20.

Theileria parasites secrete a prolyl isomerase to maintain host leukocyte transformation.

Marsolier J, Perichon M, DeBarry JD, Villoutreix BO, Chluba J, Lopez T, Garrido C, Zhou XZ, Lu KP, Fritsch L, Ait-Si-Ali S, Mhadhbi M, Medjkane S, Weitzman JB.

Nature. 2015 Apr 16;520(7547):378-82. doi: 10.1038/nature14044. Epub 2015 Jan 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk